These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34375009)

  • 21. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
    Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
    Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
    Li A; Xiao X; Feng ZL; Chen X; Liu LJ; Lin LG; Lu JJ; Zhang LL
    Toxicol Appl Pharmacol; 2020 Jan; 389():114882. PubMed ID: 31953203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway.
    Li X; Huang K; Liu X; Ruan H; Ma L; Liang J; Cui Y; Wang Y; Wu S; Li H; Wei Y; Li Z; Gao J; Yang B; Li X; Yang G; Zhou H; Yang C
    Front Pharmacol; 2021; 12():639574. PubMed ID: 33912053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
    Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
    Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway.
    Kim KH; Lee S; Lee H; Shin D; Min D; Kim M; Ryu B; Kim HW; Bae H
    Sci Rep; 2018 Nov; 8(1):16860. PubMed ID: 30443024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
    Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
    Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEDF is an antifibrosis factor that inhibits the activation of fibroblasts in a bleomycin-induced pulmonary fibrosis rat model.
    Qin X; Jia C; Liang J; Chen J; Liu X; Chao Z; Qin H; Yuan Y; Liu Z; Zhang Z; Dong H; Zhang H
    Respir Res; 2022 Apr; 23(1):100. PubMed ID: 35459189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-β1/Smad2, Nrf2 signaling and metabolomic analysis in mice.
    Washimkar KR; Tomar MS; Kulkarni C; Verma S; Shrivastava A; Chattopadhyay N; Mugale MN
    Life Sci; 2023 Oct; 331():122064. PubMed ID: 37657527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Sheng H; Lin G; Zhao S; Li W; Zhang Z; Zhang W; Yun L; Yan X; Hu H
    Front Pharmacol; 2022; 13():771031. PubMed ID: 35747752
    [No Abstract]   [Full Text] [Related]  

  • 33. RNF130 protects against pulmonary fibrosis through suppressing aerobic glycolysis by mediating c-myc ubiquitination.
    Zhang J; Chen W; Du J; Chu L; Zhou Z; Zhong W; Liu D; Huang H; Huang Y; Qiao Y; Meng X; Zou F; Cai S; Dong H
    Int Immunopharmacol; 2023 Apr; 117():109985. PubMed ID: 36893517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function.
    Xiong W; Chen S; Xiang H; Zhao S; Xiao J; Li J; Liu Y; Shu Z; Ouyang J; Zhang J; Liu H; Wang X; Zou H; Chen Y; Chen A; Lu H
    Pulm Pharmacol Ther; 2023 Aug; 81():102228. PubMed ID: 37295666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
    Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
    Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
    Miao Y; Wang Y; Bi Z; Huang K; Gao J; Li X; Li S; Wei L; Zhou H; Yang C
    BMC Pulm Med; 2023 Mar; 23(1):94. PubMed ID: 36949426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenbendazole Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Suppression of Fibroblast-to-Myofibroblast Differentiation.
    Wang L; Xu K; Wang N; Ding L; Zhao W; Wan R; Zhao W; Guo X; Pan X; Yang J; Rosas I; Yu G
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.